Clinical Trial

Dose-Response Effect of Phosphatidylserine on eSport Performance

Study acronym: EPS
Completed
View on ClinicalTrials.gov →
Summary
This study will evaluate the effects of daily phosphatidylserine supplementation on electronic gaming performance, cognitive function, sleep quality, stress-related outcomes, and autonomic responses in healthy adult gamers. Participants will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group study and assigned to receive placebo, 100 mg phosphatidylserine, or 200 mg phosphatidylserine daily for 6 weeks. Outcome measures will be assessed at baseline, Week 3, and Week 6 and will include electronic gaming performance, cognitive function, visual analog scale ratings, sleep quality questionnaires, hemodynamic responses, and heart rate variability. The study is designed to determine whether daily phosphatidylserine supplementation can improve performance and selected physiological and psychological outcomes during prolonged electronic gaming sessions.
Trial Details
NCT Number NCT07533032
Lead Sponsor Lindenwood University
Conditions Cognitive Function, Gaming Performance
Enrollment 80 participants
Start Date 2021-06-15
Primary Completion 2025-04-14 (estimated)
Study Completion 2025-04-14 (estimated)
Updated on ClinicalTrials.gov 2026-04-16